1. Home
  2. > Serinus Biosciences
Serinus Biosciences logo

Serinus Biosciences

Hitting multiple cancers with a single therapeutic

Company

Locations
New York, NY, USA / Remote
Team Size
2
Industries
Healthcare, Therapeutics
About
Serinus Bio is an AI-powered drug discovery company killing cancer with its own genetics. We unravel molecular networks to identify essential proteins that multiple cancers rely on for survival. Our platform enables drug candidates discovery in months instead of years. Supported by Y-Combinator, in only 2 months we found 3 drug candidates with a cumulative market of 110k patients per year, equivalent to over $19B. A month later we identified 20 more potential drug targets. The company was founded by Adam Yaari and Max Sherman, PhDs in cancer biology and machine learning from MIT. Joining the company as SAB members are Trey Ideker (scientific co-founder), William Hahn and Eliezer Van Allan, world-leading experts in cancer biology and oncology at the Dana-Farber Cancer Center, Broad Institute, and UCSD.

Founders

A list of all active founders
NameTitleEmail
Maxwell Sherman
Founder
Adam Yaari
Founder